Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian Participants
Topical efinaconazole 10% showed favorable efficacy/safety in White, Asian, and Black participants with mild-to-moderate onychomycosis. Results were generally consistent with the overall phase 3 populations and position efinaconazole as an efficacious treatment for patients, regardless of race.  .
Authors
- Ted Rosén (ORCID: https://orcid.org/0000-0002-5946-5529)
- Eric Guenin
- Tracey C. Vlahovic (ORCID: https://orcid.org/0000-0002-5310-4706)
- Linda Stein Gold
- Su Yong Choi
- Aditya K. Gupta
- Shari R. Lipner
- Boni Elewski
Publication Details
- Journal
- Journal of Drugs in Dermatology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.36849/jdd.9384
- Primary Topic
- Nail Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00